Android app on Google Play

Questcor Pharmaceuticals (QCOR) Jumps Higher on Analyst Defense

July 13, 2012 2:00 PM EDT Send to a Friend
Questcor Pharmaceuticals (Nasdaq: QCOR) is bouncing again on word analysts at BofA have confirmed that the company threatening to develop a generic form of ACTH is fraudulent.

While still down 3.4 percent, these comments are moving shares higher - something the earlier company JMP presentation was unable to do.

You May Also Be Interested In

Related Categories

Trader Talk

Related Entities

Bank of America

Add Your Comment